Efficacy and safety of telotristat ethyl in patients with carcinoid syndrome inadequately controlled by somatostatin analogs: Analysis of the completed TELESTAR extension period

D. Hörsch,M.H. Kulke,M. Caplin,L. Anthony,E. Bergsland,K. Öberg,R.R.P. Warner,P. Kunz,E. Grande Pulido,J.W. Valle,J.S. Dillon,P. Lapuerta,P. Banks,S. Jackson,M. Pavel

ANNALS OF ONCOLOGY（2017）

引用 1|浏览9

暂无评分

摘要

Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要